<\/p>\n
NovoRapid FlexPen<\/strong> is a pre-filled disposable insulin pen containing insulin aspart<\/strong> (100 units\/mL, 3 mL pen) — a rapid-acting insulin analogue<\/strong> used at meal-times (bolus insulin) in type 1 and type 2 diabetes. It has an onset of 10–15 minutes, peak effect at 1–3 hours, and total duration of 3–5 hours. Inject subcutaneously into the abdomen, thigh, or upper arm 5–15 minutes before a meal (or immediately after for unpredictable eaters). Usual dose: 0.5–1 unit per 10 g of carbohydrate, individualised to glucose, carb intake, and insulin sensitivity. Main risk: hypoglycaemia.<\/strong> Pair with a basal (long-acting) insulin in type 1 diabetes, or use alongside oral agents or basal insulin in type 2. Store unopened pens at 2–8°C; once in use, keep at room temperature < 30°C for up to 28 days.<\/p>\n<\/div>\n \ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen \u2014 geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor \u2014 nooit \u201cMedsBase\u201d of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.<\/p>\n NovoRapid FlexPen is a pre-filled disposable pen containing 3 mL (300 units) of insulin aspart, dialing 1–60 units per dose in 1-unit increments. It contains insulin aspart (100 units\/mL, 3 mL pen) manufactured by Novo Nordisk, supplied in packs of 1 or 5 pre-filled pens.<\/p>\n insulin aspart is a rapid-acting insulin analogue<\/strong> — a meal-time (“bolus”) insulin used to match the post-meal glucose rise. NovoRapid (NovoLog in the US) is the originator brand worldwide.<\/p>\n Insulin is the natural hormone the pancreas releases after meals to help cells absorb glucose. In diabetes, this insulin response is either absent (type 1) or insufficient (type 2). Meal-time insulin injections replace that response.<\/p>\n Insulin aspart is made by substituting a proline with aspartic acid at position B28 of human insulin, which prevents the insulin molecules from clumping into hexamers — so they dissociate and absorb faster than regular human insulin. This gives a pharmacokinetic profile tailored to the meal-time glucose rise:<\/p>\n This profile closely mimics physiological post-meal insulin release — much better than regular human insulin, which has a slow 30-minute onset and a long 6–8 hour tail that can cause late hypoglycaemia.<\/p>\n Timing:<\/strong> inject 5–15 minutes before each meal. If meal timing is unpredictable (young children, unwell adults), injecting just before or even immediately after the meal is acceptable — this flexibility is a key advantage of rapid-acting analogues over regular insulin.<\/p>\n Dosering:<\/strong> individualised to the patient. Common starting approaches:<\/p>\n Injection technique:<\/strong><\/p>\n Most important:<\/strong><\/p>\n Lokaal:<\/strong><\/p>\n Zeldzaam maar belangrijk:<\/strong><\/p>\n Verhoogd risico op hypoglykemie:<\/strong> sulfonylureas, meglitinides, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, propoxyphene, salicylates, sulfonamide antibiotics, somatostatin analogues, alcohol.<\/p>\n Reduce insulin effect:<\/strong> corticosteroids, oral contraceptives, thiazides, thyroid hormones, sympathomimetics, atypical antipsychotics, isoniazid, niacin, danazol, protease inhibitors.<\/p>\n Variable:<\/strong> beta-blockers (mask hypoglycaemia symptoms), lithium, octreotide.<\/p>\n In pregnancy:<\/strong> rapid-acting analogues are considered compatible and widely used. Discuss with your obstetric diabetes team.<\/p>\n Paediatric use:<\/strong> both NovoRapid and Apidra are approved for use in children (Apidra from 4 years, NovoRapid from 1 year) with appropriate paediatric dosing.<\/p>\n Yes. NovoRapid (used in most of the world) and NovoLog (used in the US and Canada) are the same drug — insulin aspart 100 units\/mL — made by Novo Nordisk. The different trade names are regional marketing, not different formulations.<\/p>\n 5–15 minutes before the meal is standard and gives the best glucose control. Injecting just before or immediately after is acceptable when meal timing is unpredictable — for young children, people with gastroparesis, or when you do not yet know how much you will eat. Injecting much later than that reduces control of the post-meal spike.<\/p>\n Eat a fast-acting carbohydrate immediately (15 g of glucose), then a slower-acting snack (bread, biscuits, sandwich) to cover the ongoing insulin action over the next 3–5 hours. Check glucose every 15–30 minutes. Severe or unresponsive hypoglycaemia needs glucagon or medical help.<\/p>\n In type 1 diabetes — yes, always. Rapid-acting insulin alone cannot provide 24-hour basal coverage, and stopping long-acting insulin in type 1 diabetes causes diabetic ketoacidosis within hours. In type 2 diabetes, NovoRapid FlexPen is often used alongside basal insulin (glargine, degludec) and oral agents.<\/p>\n No — rapid-acting analogues should not be mixed with long-acting analogues (glargine, degludec, detemir) in the same syringe. Use separate injections. You can give them at the same time with different pens.<\/p>\n Yes — rapid-acting analogues including aspart and glulisine are the standard insulins for continuous subcutaneous insulin infusion (CSII) pumps. Ask your diabetes team for pump-specific guidance.<\/p>\n Yes — once you take the first injection, the pen lasts 28 days at room temperature (below 30°C). Discard on day 29 even if insulin remains. Note the start date on the pen.<\/p>\n You can order NovoRapid FlexPen (100 units\/mL, 3 mL pen) from MedsBase in packs of 1 or 5 pre-filled pens. Insulin ships with temperature-protected packaging; worldwide shipping. Discreet packaging and genuine Novo Nordisk manufacturer stock.<\/p>\n <\/p>\n Andere producten in Chronische aandoeningen<\/strong> die klanten ook bekijken:<\/p>\n \u2705 Fast glucose control Novorapid Flexpen contains insulin.<\/p>","protected":false},"featured_media":57688,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[4343,4348],"class_list":{"0":"post-57687","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-insulin","11":"product_tag-novorapid-flexpen","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product\/57687","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/comments?post=57687"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media\/57688"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/media?parent=57687"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_brand?post=57687"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_cat?post=57687"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/nl\/wp-json\/wp\/v2\/product_tag?post=57687"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Waarom bestellen bij MedsBase<\/h3>\n
What Is NovoRapid FlexPen?<\/h2>\n
How Does NovoRapid FlexPen Work?<\/h2>\n
\n
Dosering en toediening<\/h2>\n
\n
\n
Bijwerkingen<\/h2>\n
\n
\n
\n
Geneesmiddelinteracties<\/h2>\n
Who Should Not Use NovoRapid FlexPen?<\/h2>\n
\n
Storage and Handling<\/h2>\n
\n
Veelgestelde vragen<\/h2>\n
Is NovoRapid the same as insulin aspart or NovoLog?<\/h3>\n
When should I inject NovoRapid FlexPen — before or after the meal?<\/h3>\n
What if I accidentally inject too much?<\/h3>\n
Do I need basal (long-acting) insulin too?<\/h3>\n
Can I mix NovoRapid FlexPen with long-acting insulin in the same syringe?<\/h3>\n
Can NovoRapid FlexPen be used in insulin pumps?<\/h3>\n
Does NovoRapid FlexPen expire once the pen is in use?<\/h3>\n
Where can I buy NovoRapid FlexPen online?<\/h3>\n
Gerelateerde diabetesmedicatie<\/h2>\n
\n
Gerelateerde alternatieven<\/h3>\n
\n
\n\u2705 Convenient pen design
\n\u2705 Adjustable dosing
\n\u2705 Reduced hypoglycemia risk
\n\u2705 Simple self-administration<\/p>\n